Also, we demonstrated that celastrol inhibited the transcriptional activity of PPARγ, thereby decreasing the Fabp3, Fatp1, MCAD, Fads2, and ACC1 mRNA expression in OA-induced hepatic steatosis cells. Here, ACADM is linked to fatty liver disease.